Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Minimal Residual Disease (MRD) revenue102.74M60.34%
Immune Medicine revenue67.54M39.66%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States170.28M100.00%